Feed Preview

Immune Therapies In Cancer

Immune Therapies In Cancer diagram by Designua, Shutterstock
Designua, Shutterstock

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.

Top 20 most recent papers
Journal for Immunotherapy of Cancer

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

Journal for Immunotherapy of CancerMarch 27, 2020
Lorenzo GalluzziFrancesco M Marincola
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma

Journal of Clinical Oncology : Official Journal of the American Society of Clinical OncologyMarch 27, 2020
William D TapJonathan C Trent
14
1
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors

Journal of Clinical Oncology : Official Journal of the American Society of Clinical OncologyMarch 28, 2020
Raffit HassanJohanna C Bendell
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

Status Update on Data Required to Build a Learning Health System

Journal of Clinical Oncology : Official Journal of the American Society of Clinical OncologyMarch 27, 2020
Monica M BertagnolliSean Khozin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

Reply to E. Gonzalez-Rodriguez et al

Journal of Clinical Oncology : Official Journal of the American Society of Clinical OncologyMarch 26, 2020
Charles L ShapiroJoan Neuner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

Randomized, Phase II Study of Trastuzumab Beyond Progression in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction Cancer: WJOG7112G (T-ACT Study)

Journal of Clinical Oncology : Official Journal of the American Society of Clinical OncologyMarch 27, 2020
Akitaka MakiyamaKei Muro
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes

Journal of Clinical Oncology : Official Journal of the American Society of Clinical OncologyMarch 26, 2020
Jennifer L Beebe-DimmerKathleen A Cooney
11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

Need for Androgen Deprivation Therapy in Addition to Definitive Radiation Therapy in Patients With Intermediate-Risk Localized Prostate Cancer

Journal of Clinical Oncology : Official Journal of the American Society of Clinical OncologyMarch 27, 2020
Pirus GhadjarThomas Wiegel
Proceedings of the National Academy of Sciences of the United States of America

Mixed lineage kinase 3 inhibition induces T cell activation and cytotoxicity

Proceedings of the National Academy of Sciences of the United States of AmericaMarch 27, 2020
Sandeep KumarAjay Rana
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

Increased Risk of Multiple Spontaneous Vertebral Fractures at Denosumab Discontinuation Must Be Taken Into Account

Journal of Clinical Oncology : Official Journal of the American Society of Clinical OncologyMarch 26, 2020
Elena Gonzalez-RodriguezOlivier Lamy
3
Cardiovascular Research

Aldosterone-Induced Hypertension is Sex-Dependent, Mediated by T Cells and Sensitive to GPER Activation

Cardiovascular ResearchMarch 28, 2020
Quynh Nhu DinhChristopher G Sobey
Genes & Diseases

Metabolic reprogramming in tumors: Contributions of the tumor microenvironment

Genes & DiseasesMarch 28, 2020
Andrew N LaneTeresa W-M Fan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

Reply to P. Ghadjar et al

Journal of Clinical Oncology : Official Journal of the American Society of Clinical OncologyMarch 27, 2020
Soumyajit Roy, Shawn Malone

See more papers from this feed

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Astrocytes in Repair & Regeneration

Astrocytes are glial cells found within the CNS and are able to regenerate new neurons. They become activated during CNS injury and disease. The activation leads to the transcription of new genes and the repair and regeneration of neurons. Discover the latest research on astrocytes in repair and regeneration here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Biosensor Development & Applications

Biosensor development and applications describe recent progress in biosensor development and their applications in the field of antibiotics and metabolic engineering. Discover the latest research on biosensor development and applications in this feed.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

© 2020 Meta ULC. All rights reserved
/feed-previews/immune-therapies-in-cancer/aff5d16a-1a86-423f-881f-227784d0b14f